# RenaissThera Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/renaissthera-private

- Industry: Biotechnology
- Headquarters: Bangalore, India
- Website: www.renaissthera.com/
- Latest round: Seed (Jun 23, 2026)
- Investors on record: 1

## About

Founded in 2023 and based in Karnataka, India, RenaissThera Private Limited operates as a biotechnology company that provides small-molecule therapies for Cardio-metabolic diseases. The company was co-founded by Ramkesh Meena (CEO) and Sudhir Nagarajan. In June 2026, RenaissThera Private Limited raised seed funding led by Arali Ventures. 

The company's core product offerings include therapies targeting cardio-metabolic conditions, specifically focusing on obesity and diabetes, increasingly prevalent due to rising risk factors. RenaissThera leverages advanced AI platforms to streamline drug discovery and enhance the efficacy of its treatments, striving to create affordable solutions that ensure broader accessibility for patients. 

RenaissThera engages in direct-to-consumer transactions, facilitating access to its therapies while also establishing partnerships with healthcare providers and institutions.

The company will use the June 2026 funding to advance its oral small-molecule product pipeline, optimize its lead development assets, and finance preclinical validation tracks to establish Investigational New Drug regulatory readiness.

## Funding rounds

- Seed, Jun 23, 2026 — Arali Ventures

## Investors

- Arali Ventures (https://capitalatlas.ai/funds/arali-ventures) — Seed